Latest Amines Stories

SAN DIEGO, Aug 29, 2012 /PRNewswire/ -- Proacta Incorporated announced today that the US Food and Drug Administration has allowed its Investigational New Drug (IND) Application for PR610, a hypoxia-activated, irreversible multi-kinase inhibitor (MKI) for the treatment of cancer. The IND allowance permits Proacta to initiate human clinical trials of this novel, first in class treatment. Initially, development will focus on patients with non-small cell lung cancer who have developed...

RARITAN, N.J., Aug. 29, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for NUCYNTA(® )ER (tapentadol) extended-release tablets, an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time....

HALIFAX, Nova Scotia, Aug. 24, 2012 /PRNewswire/ -- RIVALUS today announced the release of POWDER BURN the first product in the new blaqseries, a supplement line dedicated to providing innovative formulations without dangerous ingredients. POWDER BURN is the most powerful pre-workout available today with no banned substances for military personnel. (Photo: http://photos.prnewswire.com/prnh/20120824/DE62407 ) As the first company in the industry to offer sports nutrition...

Approximately one in five prescriptions to elderly people is inappropriate, according to a study published Aug. 22 in the open access journal PLOS ONE. The authors of the study, led by Dedan Opondo of the Academic Medical Center in Amsterdam, conducted a systematic review of English-language studies of medication use in the elderly and found that the median rate of inappropriate prescriptions was 20.5%. Some of the medications with the highest rates of inappropriate use were the...

BOULDER, Colo., Aug. 23, 2012 /PRNewswire/ -- Biodesix today announced that VeriStrat results from two phase II advanced lung cancer trials will be presented at the upcoming 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. The first study will be presented by Karen Reckamp, MD (City of Hope Comprehensive Cancer Center) and reports on the analysis of pre-treatment serum samples from a Phase II study evaluating erlotinib or erlotinib plus high-dose celecoxib in advanced...

LAVAL, QC, Aug. 23, 2012 /PRNewswire/ - Uniboard, a North American leader in engineered wood products, is investing $3 million to increase thermally fused melamine capacity and improve efficiency at its Sayabec, Quebec operations. The Company's Sayabec plant, already one of North America's most efficient and flexible thermally fused melamine producers, will make major investments to its TFM press #3 production line. Work will begin in the fourth quarter of 2012 with an expected...

ANNAPOLIS, Md., Aug. 9, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Department of Defense (DoD) has elected to exercise its option to accelerate funding for PharmAthene's rBChE nerve agent medical countermeasure program contingent on the achievement of key milestone activities. "We believe this is a timely decision given the recent headlines about the...

MONMOUTH JUNCTION, N.J., July 11, 2012 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company with fully integrated commercial manufacturing and drug development operations, announced today that in order to meet demand for its products (approved and near term) the company has fortified its supply chain, increased manufacturing capacity and strengthened its management team. During the past two months, Tris has been fortunate to receive five new ANDA approvals from the...

Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart. It affects several million people in Europe. AF causes a loss of contraction in the atria and gives rise to heart failure. Moreover, it is associated with a high risk of stroke. One in five strokes is due to AF. In most cases, AF can be treated successfully by an electrical cardioversion. Unfortunately, in the majority of patients, AF recurs during the first days or weeks after cardioversion. This is due to...

Bayer CropScience confirms event dates for 2012. Research Triangle Park, NC (PRWEB) June 07, 2012 In a growing number of fields across this vast country, herbicide-resistant weeds are towering over valuable crops, their branches dripping thousands of stubborn seeds that if left unchecked will infest fields and choke out profits for years to come. In the Mid-South, crews of workers are chopping pigweed that resemble small trees. These all too common sights in the Mid-South are threatening...